Tampa, FL – Medi-Weightloss® is excited to announce that Macklin Guzmán, D.H.Sc., M.P.H. has been appointed as the company’s first Chief Scientific Officer (CSO).
As CSO, Dr. Guzmán will continue to lead Medi-Weightloss® in research and development activities that will promote clinical research in obesity medicine and augment evidence-based best practices. He will be responsible for envisioning and developing research capabilities that will further enhance the Medi-Weightloss® Brand and provide scientific evidence on the benefits, challenges, and results of the various programs, products, and services offered. Dr. Guzmán will continue to be an avid spokesperson in communicating with the medical and scientific community, as well as the public about why Medi-Weightloss® is The One That Works!®
As Medi-Weightloss® expands its collaborative initiatives into the pharmaceutical sector, Dr. Guzmán will serve as the medical science liaison between Medi-Weightloss® and pharmaceutical executives, scientists, and clinicians. One goal is to introduce additional anti-obesity pharmacotherapies to the National Brand’s formulary that aim to sustain and maintain patients’ weight loss goals. Dr. Guzmán and his team will continue to foray into current research efforts through clinical trials, data analytics, and manuscript submissions to peer-reviewed journals. He will also continue to oversee the Medi-Weightloss® national Scientific Advisory Board, an interdisciplinary team of health experts that are dedicated to quality assurance and the timely integration of clinical research findings into patient care.
Dr. Guzmán is an experienced epidemiologist and clinical scientist with research interests in chronic and infectious diseases. He has significant clinical lab and healthcare experience and knowledge in the areas of epidemiology, biostatistics, bioethics, clinical research, diagnostic microscopy, and translational science. Dr. Guzmán received his Bachelor of Arts from Brandeis University, his Master of Public Health from Yale University, and his Doctor of Health Science from Nova Southeastern University’s College of Health Care Sciences.
Established in 2005, Medi-Weightloss® offers a physician-supervised weight loss program. Physicians and medical professionals provide individualized care based on a patient’s goals, health, and medical history. The program includes weekly consultations that focus on nutrition, lifestyle, and exercise. In addition to weight loss programs for adults that have resulted in more than 3 million pounds lost nationwide, Medi-Weightloss® has specialized weight loss programs for adolescents and diabetics. The company also offers a Corporate Wellness Program, InterActive Exercise, and Signature Supplements & Products. Currently, there are over 130 franchises sold in 31 states.
Dr. Guzmán is available for interviews regarding:
- The Obesity Epidemic
- Public Health
- Interpretation of Clinical Research
Rhandi Guzzo: Rhandi@mediweightloss.com 813-549-7266